SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-23-032632
Filing Date
2023-02-10
Accepted
2023-02-10 16:20:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d573388dsc13ga.htm SC 13G/A 41682
  Complete submission text file 0001193125-23-032632.txt   43460
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
Seagen Inc. (Filed by) CIK: 0001060736 (see all company filings)

IRS No.: 911874389 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110
Business Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Subject) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88917 | Film No.: 23612223
SIC: 2834 Pharmaceutical Preparations